SOST and Huntington disease: From the perspective of SOST as an uremic vascular calcification inhibitor, previous study showed that higher serum level of SOST was intricately involved in lower short-term (18-month) cardiovascular mortality and inversely associated with serum iPTH and alkaline phosphatase levels in HD patients [25].